Colossal Biosciences

📍 Dallas, United States👥 264 employees💰 Last funded Jul 2025
Biotechnology Research🌐 colossal.com
Website LinkedIn
Making extinction a thing of the past. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.
23
Total investors
10
Early stage
1
Mid stage
0
Late stage
—
Founded

Investors

23 investors
All
Early stage
Mid stage
Late stage
Angel investors· 2
John Thomas Marino
John Thomas Marino
Founder @ Marino | Co-founder of Tuft & Needle | Practicing Catalyst, Maker, and Angel Investor
Angel Investor
4 investments
May 2021
RI
Rayyan Islam
Investor. Entrepreneur. Activist. Merchant of Decarbonization. UN Delegate. Forbes 30u30 Fellow
Angel Investor
early stage
28 investments
2021
Series A· 1
Juan Felipe Campos
Juan Felipe Campos
Growth Hacking || AI GTM
Investor (Series A and Series B - $225M Raised)
early stage
4 investments
Nov 2021
Early stage· 8
An V.
An V.
Founder + Engineer | prev. at NASA Jet Propulsion Lab
early stage
Dec 2022
Ξ Marcelo D.
Ξ Marcelo D.
Partner at Cluster Capital
early stage
17 investments
Jan 2022
Hisham Elhaddad
Hisham Elhaddad
Co-Founder & Managing Partner at HOF Capital
early stage
27 investments
Nov 2021
Phil Brady
Phil Brady
Founding Partner @GoAhead Ventures | ex-Andreessen Horowitz | Forbes 30U30
early stage
10 investments
Oct 2021
Daniel Breyer
Daniel Breyer
Partner at Breyer Capital | Co-Founder of Flare
early stage
30 investments
Jun 2021
Jonathan Swerdlin
Jonathan Swerdlin
Co-founder & CEO at Function
early stage
43 investments
Apr 2021
Justin Waldron
Justin Waldron
founder @ zynga, playable intelligence, playco
early stage
3 investments
2021
Vincent Cordero
Vincent Cordero
Venture Capitalist & fmr C-Suite Executive
Co-Founder & Investor
early stage
10 investments
2020
Mid stage· 1
Danny Chan
Danny Chan
Managing Director @ Iconic Private Equity Partners | Film Producer | Film Financier
Investor and Advisor
mid stage
Oct 2024
Other investors· 11
Kalika Farmer
Kalika Farmer
Managing Partner at Delphi
14 investments
Jul 2025
Pip Deely
Pip Deely
Founder & Managing Partner at Delphi VC | Investor in Longevity, AI x Biology & Frontier Healthcare
10 investments
Jun 2025
Václav Krůta
Václav Krůta
I help capital grow. Founder @ Investing Wolf Private deals | Strategic investments | Global network
Private Investor
5 investments
May 2025
Show all 23 investors ↓
Investor geography3 countries
United States
20
United Kingdom
2
Canada
1
Investor activity2020–2025 · investors recorded per year
2020120211120223202312024320254
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Colossal Biosciences?
Colossal Biosciences has 23 investors on record on gritt.io, including 10 early-stage backers, 1 mid-stage.
When did Colossal Biosciences last raise funding?
The most recent investment in Colossal Biosciences recorded on gritt.io was in July 2025.
What industry is Colossal Biosciences in?
Colossal Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Colossal Biosciences based?
Colossal Biosciences is headquartered in Dallas, United States.